Let’s take a look at why Onconova Therapeutics, Inc. (ONTX) surged in the Postmarket hours

ASTR Stock

Onconova Therapeutics, Inc. (NASDAQ: ONTX), shares rose above 37% to 0.586 in the post-‎market session today after the news that it has earned the U.S. Food and Drug ‎Administration (FDA) clearance for a Phase 1 analysis to continue with ON 123300, a ‎proprietary, differentiated, first-in-class multi-kinase inhibitor, under the Company’s ‎Investigational New Drug Application (IND).‎ […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.